Navigation Links
Jay Leno Puts EECP In National Spotlight With Monologue Joke
Date:1/15/2014

Los Angeles, California (PRWEB) January 15, 2014

Jay Leno put EECP® (Enhanced External Counterpulsation) by Global Cardio Care centers, the leaders in EECP treatment, in the national spotlight with a joke during his monologue Jan. 10, 2014. While Sara Soulati, CEO of Global Cardio Care, showcased the blood circulation machine called EECP with a patient on the bed, Leno described the machine as “a way to improve blood circulation; it looks dirty, but it’s not.”

Global Cardio Care and EECP were the featured topics on KTLA-TV (NBC-5) in Los Angeles Jan. 9, 2014. Global Cardio Care is the gold standard in EECP, and it launched in 2002. The company manages the world’s largest physician centers delivering EECP with 22 beds.

"EECP is one of the most powerful therapies to prevent and fight cardiovascular disease," said Sara Soulati, CEO and founder of Global Cardio Care, Inc. "When Jay Leno featured me showcasing EECP during his monologue, we took it for what it was -- a joke, a few laughs, and more national attention for EECP -- exactly what we need!"

What Is EECP

EECP is a circulation therapy that treats and prevents cardiovascular disease, stroke, diabetes, high blood pressure, chest pain, and many other diseases and illness.

When a patient receives the therapy, they lie on a comfortable bed hooked to a heart monitor. Three blood-pressure-type cuffs wrap around calves, thighs and buttocks. When the heart is at rest, the cuffs squeeze the lower extremities in rapid sequence.

When the cuffs squeeze:

  •     More nitric oxide is secreted within arterial walls that reduces arterial stiffness, reduces high blood pressure and improves cardiovascular disease.
  •     New arteries grow naturally with an increase in vascular endothelial growth factor. This hormone stimulates growth of new arteries called collaterals that improve circulation and blood flow around blockages, like a natural bypass.
  •     Organs regenerate due to EECP treatment. Regenerative therapy is the process of replacing or regenerating human cells and tissue to restore and establish normal function.

About Global Cardio Care

Global Cardio Care® Inc. was launched in 2002 by Sara Soulati, CEO and founder. She and her team manage physician practices that deliver EECP, a circulation therapy that regenerates all organs while growing new arteries (angiogenesis). With 22 beds operating in two centers in Los Angeles, Global Cardio Care is the leader and gold standard in management of the world’s largest independent physician EECP centers. To schedule a free EECP trial, contact 310-412-8181. Learn more at http://GlobalCardioCare.com and follow the company on Facebook, Twitter and Google+.

Read the full story at http://www.prweb.com/releases/GlobalCardioCare/EECP/prweb11489832.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. MU receives national award for using mind-body approach to improve health
2. International breast health global summit will focus on supportive care and quality of life
3. International conference to explore health of descendants of transatlantic slave trade
4. National poll: Low cost, lifesaving services missing from most older patients health care
5. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
6. Kessler Foundation researchers present at first International Congress on Cognition in MS
7. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
8. Georgetown physician leads national resveratrol study for Alzheimers disease
9. National initiative launched to change the way biology departments approach undergraduate education
10. Boston researcher, surgical oncologist receives national award
11. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... Guide ...      , No matter on which side of the Atlantic devicemakers do ... device regulations they have to follow. , In addition to the full text of ...
(Date:6/28/2017)... ... , ... Anyone with a remote control has seen the never-ending twists on the house flipping ... get rich in no time. But what about the buyers of the flipper's flip. ... of a flipped house. An email recently sent to Gary Case said, “Just closed ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold & ... for the Illinois State Bar Association , in accordance with the organization’s rules of ... following a state-wide election and served in that capacity for the past year prior to ...
(Date:6/28/2017)... ... , ... American Farmer proudly announces the participation of Pure Line Seeds, Inc ... to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... seed. As demand grew, the small company located in Moscow, Idaho extended its sales ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Md. , June 7, 2017  Novavax, Inc., (Nasdaq: ... second of two Phase 2 trials of its RSV F ... of child bearing age have been published in the journal ... publication have been shared in prior scientific conferences). The Company ... in April 2014. Novavax is developing the RSV F Vaccine ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: